POCT Leads the Global IVD Market

Press release   •   Apr 25, 2013 12:50 IST

According to a new report by RNCOS, “In-Vitro Diagnostics Market Analysis to 2017”, POCT led the global IVD market by generating revenue of around US$ 15 Billion, of which US alone accounted for around 46 % of the market share. In future, significant developments are expected to be observed in fast growing economies of India, Brazil, China, and others on the back of increasing awareness among patients. In addition, new and advanced methods that provide rapid results at the point of care, ultimately lowering the overall healthcare expenditure per patient, will experience a significant boost in developed economies.

Moreover, our research has revealed that Roche Diagnostics is the clear leader of the global POCT market accounting for 21% of the market share followed by J&J, Alere and Abbott Diagnostics as major players. Most of these players manufacture self monitoring glucose devices which account for a majority of their POCT revenue.

The report provides a thorough analysis of key IVD markets across the globe to highlight regions with the highest potential for growth. Besides, the report has delved into the business dynamics of the major players of the market. To provide a thorough understanding of the company’s business model, company’s current and historical financials have been analyzed. Moreover, each company’s strengths and weaknesses along with their recent industrial activities have also been assessed. This will help the reader to gain a deeper insight into the current competitive landscape and position its company accordingly.

The study also includes a rational analysis of the current status and expected position of the market by 2017. It facilitates the future forecasts on the total IVD market, clinical segments and regional markets. The analysis of the emerging sectors and key players in the market provides a holistic view to the reader. Explaining some of the constraints faced by the industry, the study also covers the emerging trends which would have a positive impact on the market growth. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify key opportunities and design suitable business strategies.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM472.htm

Some of our Related Reports are:

- US Telelaparoscopy Opportunity Analysis (http://www.rncos.com/Report/IM469.htm)
- US Proton Therapy Market Analysis to 2017 (http://www.rncos.com/Report/IM465.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.